Related Experiment Video
Updated: Jun 16, 2026

Rapid and Efficient Generation of Recombinant Human Pluripotent Stem Cells by Recombinase-mediated Cassette Exchange in the AAVS1 Locus
Published on: November 20, 2016
Homologous recombination in human iPS and ES cells for use in gene correction therapy
1Department of Human Genome Research, Kazusa DNA Research Institute, 2-6-7 Kazusa-Kamatari, Kisarazu, Chiba 292-0818, Japan. nmanabu@kazusa.or.jp
Abstract:
The emergence of induced pluripotent stem (iPS) cell technology has shifted gene correction therapy toward reality. Crucial issues are ensuring the safety of using iPS cell technology in patients and discovering how best to transfer genetically manipulated iPS cells back into patients. One key issue that has hindered progress of gene correction therapy, however, is the inability to achieve efficient homologous recombination in human iPS cells. This review focuses on recently developed technologies that aim to improve homologous recombination in human embryonic stem cells and on their application to iPS cells.
More Related Videos
Related Concept Videos
iPS Cell Differentiation
Homologous Recombination
Somatic to iPS Cell Reprogramming
EPS and iPS Cells in Disease Research
Induced Pluripotent Stem Cells
Somatic cells are...
Induced Pluripotent Stem Cells

